Brett T. Lund

1.4k total citations
35 papers, 1.1k citations indexed

About

Brett T. Lund is a scholar working on Immunology, Pathology and Forensic Medicine and Molecular Biology. According to data from OpenAlex, Brett T. Lund has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 13 papers in Pathology and Forensic Medicine and 4 papers in Molecular Biology. Recurrent topics in Brett T. Lund's work include Multiple Sclerosis Research Studies (13 papers), Immunotherapy and Immune Responses (8 papers) and T-cell and B-cell Immunology (7 papers). Brett T. Lund is often cited by papers focused on Multiple Sclerosis Research Studies (13 papers), Immunotherapy and Immune Responses (8 papers) and T-cell and B-cell Immunology (7 papers). Brett T. Lund collaborates with scholars based in United States, United Kingdom and Israel. Brett T. Lund's co-authors include Leslie P. Weiner, Wendy Gilmore, Alexandre Bonnin, Harry Openshaw, Nick Goeden, Yen Chan, George M. Anderson, Juan C. Velasquez, David Ko and Eve E. Kelland and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Brett T. Lund

35 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brett T. Lund United States 16 449 423 195 159 124 35 1.1k
Carla Buttinelli Italy 22 449 1.0× 676 1.6× 154 0.8× 268 1.7× 116 0.9× 55 1.6k
Peter Riskind United States 19 353 0.8× 295 0.7× 137 0.7× 190 1.2× 116 0.9× 31 1.5k
Sarah Orton United Kingdom 15 515 1.1× 933 2.2× 144 0.7× 219 1.4× 61 0.5× 27 1.4k
John R. Richert United States 18 567 1.3× 377 0.9× 155 0.8× 216 1.4× 169 1.4× 38 1.5k
Robert Heard Australia 21 557 1.2× 414 1.0× 268 1.4× 242 1.5× 107 0.9× 51 1.3k
Katie Kinsella Ireland 17 445 1.0× 413 1.0× 112 0.6× 96 0.6× 107 0.9× 22 1.0k
Cláudia Cristina Ferreira Vasconcelos Brazil 19 283 0.6× 534 1.3× 143 0.7× 101 0.6× 33 0.3× 62 966
Simona Malucchi Italy 21 350 0.8× 875 2.1× 376 1.9× 143 0.9× 85 0.7× 52 1.3k
Kyoko Fujita Japan 19 419 0.9× 216 0.5× 70 0.4× 147 0.9× 98 0.8× 59 1.4k
Georg Pilz Austria 18 151 0.3× 278 0.7× 145 0.7× 97 0.6× 43 0.3× 53 875

Countries citing papers authored by Brett T. Lund

Since Specialization
Citations

This map shows the geographic impact of Brett T. Lund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett T. Lund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett T. Lund more than expected).

Fields of papers citing papers by Brett T. Lund

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brett T. Lund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett T. Lund. The network helps show where Brett T. Lund may publish in the future.

Co-authorship network of co-authors of Brett T. Lund

This figure shows the co-authorship network connecting the top 25 collaborators of Brett T. Lund. A scholar is included among the top collaborators of Brett T. Lund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brett T. Lund. Brett T. Lund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Telesford, Kiel M., Lilyana Amezcua, Brett T. Lund, et al.. (2023). Understanding humoral immunity and multiple sclerosis severity in Black, and Latinx patients. Frontiers in Immunology. 14. 1172993–1172993. 9 indexed citations
2.
Zhao, Qiuying, Russell E. Jacobs, Berislav V. Zloković, et al.. (2022). Prenatal disruption of blood–brain barrier formation via cyclooxygenase activation leads to lifelong brain inflammation. Proceedings of the National Academy of Sciences. 119(15). e2113310119–e2113310119. 30 indexed citations
3.
Beecham, Ashley, Lilyana Amezcua, Ángel Chinea, et al.. (2022). Ancestral risk modification for multiple sclerosis susceptibility detected across the Major Histocompatibility Complex in a multi-ethnic population. PLoS ONE. 17(12). e0279132–e0279132. 7 indexed citations
4.
Kelland, Eve E., et al.. (2021). Immune Regulatory Cell Bias Following Alemtuzumab Treatment in Relapsing-Remitting Multiple Sclerosis. Frontiers in Immunology. 12. 706278–706278. 8 indexed citations
5.
Gilmore, Wendy, Brett T. Lund, Eve E. Kelland, et al.. (2020). Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis. Journal of Neuroinflammation. 17(1). 189–189. 39 indexed citations
6.
Liu, Siyu, et al.. (2019). Activation of the Protective Arm of the Renin Angiotensin System in Demyelinating Disease. Journal of Neuroimmune Pharmacology. 15(2). 249–263. 11 indexed citations
7.
Kim, Sun Young, Eve E. Kelland, Brett T. Lund, et al.. (2017). The influence of retinoic acid on the human oligodendrocyte precursor cells by RNA-sequencing. Biochemistry and Biophysics Reports. 9. 166–172. 11 indexed citations
8.
Goeden, Nick, Juan C. Velasquez, Yen Chan, et al.. (2016). Maternal Inflammation Disrupts Fetal Neurodevelopment via Increased Placental Output of Serotonin to the Fetal Brain. Journal of Neuroscience. 36(22). 6041–6049. 191 indexed citations
9.
Lund, Brett T., et al.. (2013). Assessment of changes in immune measures of multiple sclerosis patients treated with laquinimod. Journal of Neuroimmunology. 263(1-2). 108–115. 15 indexed citations
10.
Zhong, Jiang F., Yahui Song, Jing Du, et al.. (2007). Gene Regulation Networks Related to Neural Differentiation of hESC. Gene Expression. 14(1). 23–34. 6 indexed citations
11.
Lund, Brett T., et al.. (2006). Association of MBP peptides with Hsp70 in normal appearing human white matter. Journal of the Neurological Sciences. 249(2). 122–134. 21 indexed citations
12.
Lund, Brett T., Huy Q. Ta, Susan Groshen, et al.. (2004). Increased CXCL8 (IL-8) expression in Multiple Sclerosis. Journal of Neuroimmunology. 155(1-2). 161–171. 111 indexed citations
13.
Lund, Brett T. & Thomas Barrett. (2000). Rinderpest virus infection in primary bovine skin fibroblasts. Archives of Virology. 145(6). 1231–1237. 6 indexed citations
14.
Correale, Jorge, Wendy Gilmore, John P. Walsh, et al.. (2000). Resistance to glucocorticoid-induced apoptosis in PLP peptide-specific T cell clones from patients with progressive MS. Journal of Neuroimmunology. 109(2). 197–210. 26 indexed citations
15.
Correale, Jorge, Brett T. Lund, Minnie McMillan, et al.. (2000). T cell vaccination in secondary progressive multiple sclerosis. Journal of Neuroimmunology. 107(2). 130–139. 68 indexed citations
16.
Openshaw, Harry, Olaf Stüve, Jack P. Antel, et al.. (2000). Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor. Neurology. 54(11). 2147–2150. 134 indexed citations
17.
Evans, Clive W., Brett T. Lund, I. McConnell, & Raymond Bujdoso. (1994). Antigen recognition and activation of ovine gamma delta T cells.. PubMed. 82(2). 229–37. 13 indexed citations
18.
Lund, Brett T., et al.. (1993). 6.12 Expression of T19 (WC1) molecules by ovine lymphocytes. Veterinary Immunology and Immunopathology. 39(1-3). 145–153. 10 indexed citations
19.
Bujdoso, Raymond, et al.. (1993). 6.7 Different rates of interleukin 2 receptor expression by ovine γ/δ and α/β T cells. Veterinary Immunology and Immunopathology. 39(1-3). 109–114. 14 indexed citations
20.
Omenn, Gilbert S., Gary E. Goodman, Linda Rosenstock, et al.. (1988). The Role of Intervention Studies in Ascertaining the Contribution of Dietary Factors in Lung Cancer. Annals of the New York Academy of Sciences. 534(1). 575–583. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carla Buttinelli Breakdown of academic impact, for papers by Peter Riskind Breakdown of academic impact, for papers by Sarah Orton Breakdown of academic impact, for papers by John R. Richert Breakdown of academic impact, for papers by Robert Heard Breakdown of academic impact, for papers by Katie Kinsella Breakdown of academic impact, for papers by Cláudia Cristina Ferreira Vasconcelos Breakdown of academic impact, for papers by Simona Malucchi Breakdown of academic impact, for papers by Kyoko Fujita Breakdown of academic impact, for papers by Georg Pilz
Rankless by CCL
2026